Join Us at Asia Beauty & Healthcare Show 2025
AM Biotech is excited to unveil two groundbreaking themes at this year's "Asia Beauty & Healthcare Show" (part of the Asia Biotech Exhibition series): Cosmetic Hair Growth and CDMO (Targeting
ExoGiov® Innovation: AM Biotech Accelerates European Expansion
ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."
AM Biotech Wins Prestigious 「National Innovation Award」, Leading the Way in Bio-Pulsed Exosome Research
AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research
AM Bio Tech Unveils ” Patented Bio-Pulsed Technology ” at Forum
AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its
With outstanding R&D achievements and impressive revenue performance, Ascension Medical Biotechnology (AM BioTech) has formed a partnership with the Medical and Pharmaceutical Industry Technology and Development Center (PITDC) to launch multiple biotech projects and enter the trillion-dollar pharmaceutical market
Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30,
【Exhibition Preview】July 25-28, AM Biotech to Showcase Innovative Technologies, Ingredients, and New Products at the Asia Healthcare & Medical Cosmetology Expo 2024
Biotechnology ✕ Beauty and Health "Asia Healthcare & Medical Cosmetology Expo 2024" showcases projects covering biotech pharmaceuticals, medicine, beauty care, and health. This year, AM Biotech is also participating, presenting
AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global
Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient
We are excited to announce our participation at 𝐈𝐧-𝐂𝐨𝐬𝐦𝐞𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟒 in Paris!
We are excited to announce our participation at 𝐈𝐧-𝐂𝐨𝐬𝐦𝐞𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟒 in Paris, April 16-18. This year, we will unveil a groundbreaking development in skincare science: the "Bio-Pulsed" Exosome. Leveraging our
According to the EUROPE DIRECT CONTACT CENTRE Consultation Response: ExoGiov Comes from SPF Eggs and Does Not Fall under the Categories Mentioned in ANNEX II/419
All cosmetics related to animal sources and derived ingredients will be labeled ANNEX II/419. However, this is only for reference and not as a basis for restriction/prohibition.
AM Biotech’s Unique Bio-pulsed Exosome, Backed by Patents, Shows Bright Prospects in the Global Market
Chairman of AM Biotech, shared the strategic layout of the “bio-pulse induced exosome Technology Platform.” With the continuous acquisition of international patents, AM Biotech’s Technology is well-positioned for international market
Chairman of AM Biotech Went to The 49th Annual Meeting of Taiwanese Dermatological Association (TDA) to Give A Special Lecture
Special Lecture at the 2024 Taiwan Dermatology Annual Conference. Discussing the efficiency and mechanism of bio-pulsed exosomes in beauty and hair growth from the perspective of miRNA and genes.
Bio-Pulsed Exosome with innovative patented technology from AM Biotech to restore health and beauty
Ascension Medical Biotechnology company(AM Biotech) from Taiwan focusing on the research and development of induced and specific functional exosome. At the seminar on innovative technologies and applications of bio-pulsed exosome
AM Biotech and Tri-Service General Hospital discussed collaboration matters regarding preclinical research and clinical trials of biochemical pulse extracellular vesicles.
AM Biotech and Tri-Service General Hospital discussed collaboration matters regarding preclinical research and clinical trials of biochemical pulse extracellular vesicles.
Chairman of AM Biotech delivered a speech at Taiwan Anti-aging and Cells Regeneration Association.
Chairman of AM Biotech delivered a speech at Taiwan Anti-aging and Cells Regeneration Association.
Cosmoprof Asia 2022 – Singapore Special Edition
Cosmoprof Asia, the leading B2B event in Asia-Pacific for all sectors of the beauty industry, will be held from 16 to 18 November 2022 at Singapore EXPO. Welcome to come
The Key to Skin Repair: The Fantastic Bio-Pulsed Exosomes
Ascension Medical Biotechnology Co., Ltd. (abbreviation: AM BioTech) is the first in Taiwan and the second in the world to obtain “Non-Human Source Stem Cell Exosomes” certified by the International
2022 Asia Healthcare & Medical Cosmetology Expo
We participated in 2022 Asia Healthcare & Medical Cosmetology Expo. Welcome to contact us! Date:2022/7/28-2022/7/31 Location:Taipei Nangang Exhibition Center, Hall 2 Booth:Q130
The Emergent Role of Exosome Therapy in 2021
Exosomes are extracellular vesicles (EV) derived from endosomes, ranging in size from 30nm to 150nm. Exosomes can be secreted by many cells. In fact, all living cells use exosomes as
The Therapeutic Potential of Exosomes
In recent years, several universities and research hospitals have conducted small-scale phase I clinical trials using exosomes. So far, only a few companies have transitioned to human clinical trials. Testing
ExoGiov® obtained International Cosmetic Ingredient Nomenclature (INCI) name
ExoGiov® obtained International Cosmetic Ingredient Nomenclature (INCI) name